Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine for prevention of perioperative neurocognitive disorder in gastrointestinal surgery
ChiCTR2200062421Phase 4Not yet recruiting
- Sponsor
- Yixing People's Hospital
- Start
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in perioperative neurocognitive disorder comparing Esketamine 0.15 mg/kg with Normal saline placebo (2 arms). Primary endpoint: Cognitive function assessment. Planned start Aug 2022; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
perioperative neurocognitive disorder
Beyond the preview
Go deeper on ChiCTR2200062421.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200062421.